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Like many medical technologies, prenatal ul-
trasonography was introduced as a routine proce-
dure without scientific evidence that it improves
foetal and neonatal morbidity and mortality. Ultra-
sound scans are now an integral part of routine fol-
low-up of pregnancy in most European countries. 
Since the eighties, ultrasonographic equip-
ment has improved to such a degree that the sen-
sitivity of ultrasonographic screening for malfor-
mations in the latest European studies is around
60%, while specificity is as high as 99%. Despite a
low prevalence (2–3%), structural malformations
account for 25% of perinatal deaths. 
Ultrasound scans may provide important in-
formation about foetal anatomy. Parents should 
be aware of the goals and limitations of this type 
of examination. In the event of lethal or severe
malformations, they will face a choice between
proceeding with the pregnancy or considering 
termination. Ultrasound examination may make it
possible to plan birth in a tertiary centre ensuring
adequate neonatal management. In some cases
prenatal ultrasound may result in an unnecessary
burden of anxiety, but it should be stressed that in
the vast majority of cases its reassuring effect is of
very significant benefit to the patient. 
The pertinence of screening for congenital
malformations is debated. Randomised studies re-
port conflicting results in evaluating morbidity and
mortality in a screened population [1, 2]. More-
over, the rate of detection varies widely, depend-
ing among other things on the organs considered
(6% to 90%) [3, 4]. Results reported by a referral
centre dealing with high-risk patients cannot be
compared with those in the general population. 
In Switzerland, payment for these examina-
tions by health insurance schemes has been chal-
lenged. The purpose of this study is to describe the
performance of ultrasound screening in the detec-
tion of major foetal malformations during a five-
year period in a general population. 
Objective: To determine the sensitivity of ultra-
sonography in screening for foetal malformations
in the pregnant women of the Swiss Canton of
Vaud.
Study design: Retrospective study over a period
of five years.
Method: We focused our study on 512 major or
minor clinically relevant malformations detectable
by ultrasonography. We analysed the global sensi-
tivity of the screening and compared the perform-
ance of the tertiary centre with that of practition-
ers working in private practice or regional hospi-
tals.
Results: Among the 512 malformations, 181
(35%) involved the renal and urinary tract system,
137 (27%) the heart, 71 (14%) the central nervous
system, 50 (10%) the digestive system, 42 (8%) the
face and 31 (6%) the limbs. Global sensitivity was
54.5%. The lowest detection rate was observed 
for cardiac anomalies, with only 23% correct
diagnoses. The tertiary centre achieved a 75%
detection rate in its outpatient clinic and 83% 
in referred patients. Outside the referral centre,
the diagnostic rate attained 47%.
Conclusions: Routine foetal examination by
ultrasonography in a low-risk population can de-
tect foetal structural abnormalities. Apart from the
diagnosis of cardiac abnormalities, the results in
the Canton of Vaud are satisfactory and justify
routine screening for malformations in a low-risk
population. A prerequisite is continuing improve-
ment in the skills of ultrasonographers through
medical education.
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In the Swiss Canton of Vaud, 38110 births were reg-
istered between January 1994 and December 1998. Dur-
ing this period, pregnant women generally underwent an
early scan at 11–14 weeks’ gestation, a second at 20–22
weeks and a third at 32–34 weeks. Scans were performed
by obstetricians, radiologists and general practitioners
either in private practice or hospitals. The only tertiary
centre in the Canton of Vaud deals with a high-risk pop-
ulation but also screens low-risk patients from its pre-
natal clinic. 
The Vaud registry of congenital anomalies is included
in the Swiss registry of EUROCAT, a European network
of population-based registries for epidemiologic surveil-
lance of congenital anomalies. Currently more than
900,000 births per year in Europe are surveyed by 36 reg-
istries in 17 European countries. To ensure a complete and
accurate database, the Vaud registry is based on multiple
sources of information [5, 6]. All live births, stillbirths and
terminations of pregnancy with a malformation demon-
strated in the prenatal or postnatal period are included.
The data are collected by one of the authors (MCA) and
contain comments on prenatal ultrasonographic descrip-
tion of the malformations. It includes information re-
garding the infant, the pregnancy and the parents.
This retrospective study focuses on major and some
minor malformations detectable by ultrasonography
divided into 6 main groups (table 1). The correlation
between ultrasound examination and postnatal or post-
mortem findings was considered true positive if the find-
ings were totally or partially confirmed. Major malfor-
mations included lethal or incurable abnormalities and
conditions associated with severe handicap or requiring
surgery. Minor malformations were likewise considered
when clinically relevant. They also afford evidence of the
quality of reporting [7] and include ventricular septal de-
fect of more than 3 mm and pyelo-caliceal dilatations. 
The sensitivity of prenatal diagnosis was studied in
relation to the various malformations. Since foetuses may
present multiple malformations, the detection rate was
also calculated in terms of malformed foetuses. In a sec-
ond analysis we compared the sensitivity observed in the
tertiary centre for low-risk patients with the results ob-
tained in the rest of the Canton of Vaud. Cases referred to
the tertiary centre for further examination included those
referred for suspected foetal abnormality or for pregnancy
follow-up in the last weeks of gestation prior to delivery
at our centre. All these cases were credited to the referring
practitioners and not to the centre. This evaluation was
performed by matching the data of the Vaud registry with
the data prospectively collected in the tertiary centre.
Fischer’s exact test was used to compare detection
rates in different populations. A p value <0.05 was consid-
ered significant.
Patients and methods
Abnormalities True False
positive negative
Central nervous system 58 13
Hydrocephalus 25 8
Anencephaly 16 1
Spina bifida 15 4
Encephalocele 2 0
Heart abnormalities 31 106
Atrioventricular canal defect 3 9
Hypoplastic left and right heart syndrome 7 2
Univentricular heart 1 3
Transposition of great vessels 2 8
Tetralogy of Fallot 0 8
Common truncus 1 1
Double outlet ventricle 1 3
Aortic arch hypoplasia 3 6
Coarctation of aorta 1 11
Cardiomyopathy 1 8
Complex malformations 4 8
Ventricular septal defect >3 mm 6 36
Miscellaneous heart malformation 1 3
Digestive system abnormalities 28 22
Miscellanous atresia 7 10
Laparoschisis 5 1
Omphalocele 8 5
Diaphragmatic hernia 8 6
Members: reduction of limbs 13 18
Kidney and urinary tract abnormalities 129 52
Bilateral renal agenesia 4 0
Unilateral renal agenesia 9 5
Bilateral multicystic dysplasia 3 0
Unilateral multicystic dysplasia 22 1
Polycystic kidneys 2 1
Exstrophy of the bladder 1 2
Other anomalies of the kidneys 5 1
Stenosis of pyelo-ureteral jonction 33 12
Double collecting system 13 6
Pyelo-caliceal dilatation 21 8
Hydronephrosis 4 2
Anomaly of the urethra 4 4
Other anomalies of the ureter 4 9
Other anomalies of the bladder 4 1
Face 21 21
Unilateral cleft lip 15 14
Bilateral cleft lip 6 7
Table 1
Detection of foetal
abnormalities by
organs involved.
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During the study period, 1270 foetal malfor-
mations were entered in the Vaud registry of con-
genital anomalies. When compared with the
38110 births, this corresponds to a prevalence of
3.3%. Of these, 512 (1.3%) were clinically relevant
major and minor malformations (table 1). They
were observed in 416 foetuses, some presenting
with multiple malformations. The most frequently
observed abnormalities involved the renal and uri-
nary tract (181/512; 35%); among cases associated
with urinary tract dilatation (stenosis of pyelo-
ureteral junction, double collecting system, pyelo-
caliceal dilatation and hydronephrosis), 71/99
(72%) were detected in the prenatal period. Uni-
lateral renal multicystic dysplasia was diagnosed in
95% of cases (22/23), and unilateral renal agene-
sia in 64% (9/14). Lesions resulting in terminal
renal failure associated with anamnios were diag-
nosed in all cases (bilateral renal agenesia and bi-
lateral multicystic dysplasia; n = 7). 
Cardiac malformations accounted for 27% of
all anomalies (n = 137). Major malformations no-
ticeable in the four-chamber view were detected in
13/36 cases (36%). Among 42 cases of ventricular
septal defect (>3 mm), 6 (17%) were diagnosed.
The detection rate for other cardiac malforma-
tions was 12/59 (20%) and the central nervous sys-
tem was involved in 71 abnormalities (14%). Most
cases of neural tube defect (84%; n = 38) and
hydrocephalus (76%; n = 33) were diagnosed on
ultrasound examination. Other cases involved the
digestive system (n = 50; 10%), the face (n = 42;
8%) and the limbs (n = 31; 6%).
Overall, foetal malformations were diagnosed
during the prenatal period in 279 cases (55%)
(table 2). The best detection rate was observed for
central nervous system anomalies (82%), followed
by renal and urinary tract (71%), digestive system
(56%), face (50%), limbs (42%) and heart malfor-
mations (23%). 
Considering foetuses as individuals presenting
one or more malformations, the overall sensitivity
of prenatal diagnosis by ultrasound was 57.2%
(238/416).
Screening outside the referral centre achieved
correct diagnosis in 175 of 374 cases (47%). The
tertiary centre achieved a 75% detection rate
among patients followed in its prenatal clinic (p
<0.001) and an 83% rate in referred cases (table 3).
The low detection rate for heart anomalies (14%
in private practice and 53% in tertiary care cen-
tres) reflects the difficulties encountered in ob-
taining the appropriate planes for thorough exam-
ination of the whole 3D anatomy of this organ. On
the other hand, the good results (50%) obtained
for a malformation reputedly difficult to see, i.e.
cleft lip, show that a complete and thorough
examination of a specific anomaly can improve its
detection.
Results 
Type of malformation sensitivity (%)
Central nervous system 82 
Heart disease 23 
Digestive abnormalities 56 
Renal and urinary tract abnormalities 71 
Facial cleft 50 
Reduction of limbs 42 
Global 55
Table 2
Sensitivity of screen-
ing in the Canton 
of Vaud.
Table 3
Sensitivity of screen-
ing in the tertiary
centre, in private
practice and in 
regional hospitals.
(A) (B) (C) A vs C
Type of malformation Tertiary centre Referred * to Non-referred and Fischer exact test
tertiary centre referred* to tertiary 
centre
Central nervous system (n = 71) 85% (17/20) 94% (33/35) 80% (41/51) 0.74
Heart disease (n = 137) 58% (15/26) 48% (14/29) 14% (16/111) <0.0001
Digestive abnormalities (n = 50) 75% (12/16) 100% (11/11) 47% (16/34) 0.07
Renal and urinary tract 80% (48/60) 90% (56/62) 66% (80/121) 0.0582
abnormalities (n = 181)
Facial cleft (n = 42) 88% (7/8) 73% (11/15) 41% (14/34) 0.044
Reduction of limbs (n = 31) 56% (5/8) 100% (6/6) 35% (8/23) 0.22
Global (n = 512) 73% (104/138) 83% (131/158) 47% (175/374) <0.0001
* Includes cases referred for suspected foetal abnormality or for pregnancy follow-up in the last weeks of pregnancy and delivery
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Prenatal ultrasonography is the best means of
diagnosing malformed foetuses [8]. However, pub-
lished results concerning the sensitivity of the
screening vary greatly, depending on the popula-
tion studied (high versus low risk), the quality of
the equipment and in particular the ultrasono-
graphers’ experience. Nowadays, high-resolution
equipment allows the detection of minor malfor-
mations considered to be sonographic markers of
specific conditions. These were not included in our
study, to maintain the homogeneity of the popula-
tion screened. We focused our attention on severe
abnormalities which can be detected by prenatal
ultrasonography.
The detection rate for congenital abnormali-
ties by routine ultrasonography in a general pop-
ulation varies from 8 to 84% [1, 2, 9–12]. Levi et
al. [13] reported 40.4% sensitivity in a study per-
formed in Belgium, Eik-Nes et al. [14] 43% in
Norway, and in the recent Eurofetus study [15] the
rate was 61.4%. Our detection rate of 55% is com-
parable to these results, as is the 47% attributed to
the practitioners working outside the tertiary cen-
tre. These results are encouraging and compare
very favourably with the detection rate of 22% for
obstetricians in the study of Bernaschek et al. [16]
and the 14% reported by Lys et al. [17]. This can
probably be explained by the effort made at the be-
ginning of the nineties in terms of post-graduate
and continuous education in this field. 
In our study, the data for some malformations
known to be rather difficult to diagnose, such as
cleft lip with or without cleft palate, show a 50%
detection rate which is in agreement with the re-
sults of the Euroscan Study Group [18]. In our re-
gion, however, efficacy of screening for heart dis-
eases is below the usual standards. Our global pre-
natal diagnosis rate for cardiac malformations is
only 22.6% compared with 45–55% reported in
the countries participating to the Euroscan Study
Group [19]. Our detailed results emphasise the
need for improved training in the field of heart,
limb and diaphragmatic anomalies.
Awareness of our screening performance in
the general population provides evidence with
which to explain the limits of ultrasonographic
examination to our patients and emphasises the
need for a network of trained ultrasonographers 
to whom difficult or high-risk cases should be re-
ferred.
We believe these results justify routine ultra-
sonographic screening for foetal malformations 
in all pregnancies. To propose screening only to
high-risk patients is discriminatory, for many rea-
sons. First, it is well known that most of the mal-
formations are discovered in the low-risk group
[20]. Second, there is no universal definition of a
high-risk pregnancy, and third, it is only after birth
that a case can be declared low-risk with certainty.
The usual high-risk patients (family history of 
congenital disease, previous pregnancy with ab-
normality) should be referred to well-trained 
ultrasonographers along with patients in whom 
ultrasonographic markers for malformations are
demonstrated (oligohydramnios, polyhydramnios,
foetal growth retardation, increased nuchal
translucency measurement in first trimester with
normal karyotype).
In conclusion, we share the view of Bucher and
Schmidt [21] who in their meta-analysis insist that
“routine ultrasound screening in pregnancy is in-
dicated only if explicitly performed to exclude con-
genital malformations”. We also agree with the
conclusion of the British Columbia Office of
Health Technology Assessment [22] that routine
ultrasonography in a low-risk population only has
sense if it forms part of a programme of prenatal
diagnosis including screening for trisomy 13, 18
and 21. Finally, ultrasound screening should be
linked to an improved detection rate for foetal mal-
formations through appropriate continuous edu-
cation, and should always be associated with the
use of informed consent protocols.
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